Skip to main content

Table 4 The IC50 values of paclitaxel, curcumin alone and in combination on MCF-7 and MCF-10A cells, administered in the forms of free drug and drug niosomal form

From: Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy

Treatment type

IC50 values

On MCF-7 cells

On MCF-10A cells

Free curcumin solution

44.60 ± 0.46

76.71 ± 0.45

Free paclitaxel solution

13.54 ± 0.28

30.75 ± 0.22

Free paclitaxel + free curcumin solution

8.36 ± 0.38

22.26 ± 0.48

Curcumin niosome

14.90 ± 0.19

64.22 ± 0.36

Paclitaxel niosome

3.73 ± 0.29

20.54 ± 0.49

Paclitaxel niosome + curcumin niosome

1.57 ± 0.1

8.89 ± 0.46

  1. Data represents the mean ± SD
  2. The values are shown as mean ± SD, n = 4